Fibrosis progression in initially mild chronic hepatitis C
✍ Scribed by S. Boccato; R. Pistis; F. Noventa; M. Guido; L. Benvegnù; A. Alberti
- Book ID
- 108885842
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 139 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Fibrosis progression is the main determinant of liver disease outcome in chronic hepatitis C, being influenced by environmental and host factors. Recently, a cirrhosis risk score (CRS) based on seven single-nucleotide polymorphisms was proposed as genetic predictor of cirrhosis in hepatitis C. To as
In patients with mild hepatitis C, the usefulness of antiviral therapy is subject of debate, as a low risk for progression of fibrosis is assumed. Several studies have shown that steatosis is a strong and independent predictor of the severity as well as the progression of fibrosis in chronic hepatit
of scavenger receptor, class B, type I, a high density lipoprotein receptor, operative within the hepatocyte interior (such as regulators in liver and steroidogenic tissues of the rat. J Clin Invest 1996;98:984of cholesterol biosynthetic pathways), at the basolateral 995. membrane (such as regulato